TATVACommodities

Tatva Chintan Pharma Chem Limited

Specialty Chemicals · ISIN INE0GK401011 · BSE 543321 · NSE EQ · FV ₹10
Last price
₹1,710
+3.81%today
What this company does

Tatva Chintan Pharma Chem Limited operates in Specialty Chemicals, part of the Commodities sector. It booked ₹167 cr of revenue in its latest quarter (Q1 FY27) and kept 9.6% of sales as profit.

In the report:
49out of 100
Equitytale Health Score
Mixed

Healthier than 49% of companies in Commodities, on all six measures of filed financials. Each measure is ranked against the 91–173 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
56

At close. Not part of the score.

Profitability & returns49

How much profit it earns on the money it employs

Balance sheet61

How much it owes, and whether earnings cover the interest

Cash quality19

Whether reported profit actually arrives as cash

Growth & consistency69

Whether sales and profit have grown, and how steadily

Valuation7

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Is this company doing well?
not investment advice
Strengths
Makes a profit
Sales up 43% vs last year
Profit up 140% vs last year
Promoters hold 72%
No promoter shares pledged
Turns profit into real cash
Watch-outs
None flagged from our data

What if I invest in TATVA?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh

The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹1,710 +3.81%
latest close · 2026-09-17
1-year return
-20.1%
52-wk low ₹1,52052-wk high ₹2,978
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio62.6High
LowAverageHigh
P/B ratio5.12High
Below bookModerateHigh
EV / EBITDA30.5High
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity8.2%Fair
WeakFairStrong ▸15%
Return on capital11.7%Fair
WeakFairStrong
Net margin9.6%Decent
ThinDecentStrong
EBITDA margin20.2%Healthy
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.15Comfortable
LowModerateHigh ▸1
Interest cover11.1×Strong
RiskyOkayStrong ▸5×
Current ratio1.64Healthy
Tight ◂1HealthyAmple
More figures
Market cap
₹3,999 cr
Book value
₹334
EPS
₹6.83
latest quarter
Net debt
₹115 cr
owes more than its cash
Enterprise value
₹4,114 cr
EBITDA
₹135 cr
annualised
EBIT
₹93 cr
annualised
Operating margin
13.9%
Return on assets
6.4%
Earnings yield
1.60%
P/S
5.98
Sales / share
₹285.7
Tax rate
24.3%
Face value
₹10
Shares
2.3 cr
Working capital
₹136 cr
Current assets
₹350 cr
Current liabilities
₹213 cr
Delivery %
48.6%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the FY 2025 report & filings
not investment advice
Hard to value confidentlyLow confidence
The market price is far above what these earnings- and book-based models support — a fast-growing or asset-light business can trade well above them for years, so we won't put a confident number on how overpriced it is.
Models span ₹368₹390, midpoint ₹379

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹167 cr
Other Income₹3 cr
Total Income₹170 cr
Cost of Materials₹105 cr
Purchases of Stock-in-Trade₹1 cr
Inventory Change (±)₹-32 cr
Employee Benefit Expense₹17 cr
Finance Costs₹2 cr
Depreciation & Amortisation₹11 cr
Other Expenses₹43 cr
Total Expenses₹147 cr
Exceptional Items₹-1 cr
Profit before Tax₹21 cr
Tax Expense₹5 cr
Net Profit₹16 cr
Net margin on total income9.4%
Where the money goes · Q1 FY27
% of total income
Materials + stock-in-trade₹75 cr44.7%
Employee benefit expense₹17 cr9.9%
Finance costs₹2 cr1.2%
Depreciation & amortisation₹11 cr6.3%
Other expenses₹43 cr25.4%
Tax expense₹5 cr3.0%
Profit for the period₹16 cr9.5%
Total income ₹170 cradds up to ₹100 ✓
Quarterly results · consolidated (₹ cr)
MetricQ3 FY26Q4 FY26Q1 FY27
Revenue131 cr134 cr167 cr
Total income133 cr134 cr170 cr
Expenses115 cr117 cr147 cr
Profit before tax18 cr17 cr21 cr
Tax2 cr6 cr5 cr
Net profit (owners' share)15 cr10 cr16 cr
Net margin (owners' share, on revenue)11.5%7.7%9.6%
EPS (₹)6.494.416.83
YoY (latest quarter): total income +43.9% · net profit +140.3%
Balance sheet & cash flow · as of Mar 2026
Low debt
Total assets
₹1,004 cr
Shareholder equity
₹782 cr
parent shareholders
Total debt
₹120 cr
Cash
₹6 cr
Cash flow · H1 FY26
Operating
₹13 cr
Investing
₹-58 cr
Financing
₹46 cr
Peer comparison
Specialty Chemicals · by market value
CompanyPriceMarket capP/E
Pidilite Industries Limited₹1,552₹1.58 L cr45.3
Gujarat Fluorochemicals Limited₹4,472₹49,190 cr55.4
Navin Fluorine International Limited₹8,220₹42,169 cr43.3
Deepak Nitrite Limited₹1,605₹21,889 cr15.9
Aether Industries Limited₹1,623₹21,543 cr85.1
Atul Limited₹6,134₹18,057 cr18.4
Aarti Industries Limited₹477₹17,287 cr27.9
Fine Organic Industries Limited₹5,202₹15,949 cr28.9
BASF India Limited₹3,602₹15,591 cr11.2
Same industry · latest reported numbers · not a recommendation.
Corporate actions
Dividend yield
0.12%
trailing 12 months
Dividend / share (TTM)
₹2
Last dividend
₹2
ex 11 Sep 2026
ActionDetailEx-date
Dividend₹2 / share11 Sep 2026
Dividend₹1 / share12 Sep 2025
Dividend₹2 / share6 Sep 2024
Dividend₹2 / share8 Sep 2023
Dividend₹2 / share8 Sep 2022
Who owns it · 2026-06-30
No pledge
Promoter
72.0%
FII / Foreign
3.9%
DII / Domestic
3.1%
Retail / others
20.9%
Smart-money activity
Insider trades
BoughtAjay Mansukhlal Patel · Promoters7.15 L6 Feb 26
SoldAjay Mansukhlal Patel (HUF) · Promoter Group7.15 L6 Feb 26
SoldPriti Ajay Patel · Promoter Group20,211 · ₹3.4 cr6 Sep 23
Bulk / block deals
SoldMUSIGMA SECURITIES · NSE1.44 L @ ₹1,262.5115 Oct 25
BoughtMUSIGMA SECURITIES · NSE1.44 L @ ₹1,262.1415 Oct 25
SoldGRAVITON RESEARCH CAPITAL LLP · NSE1.34 L @ ₹1,212.7415 Oct 25
Stake changes
SoldAjay Mansukhlal Patel (HUF) along with pac · promoter→ 0.00% · 7.15 L6 Feb 26
BoughtAjay Mansukhlal Patel along with pac · promoter→ 20.16% · 7.15 L6 Feb 26
SoldNippon India Mutual Fund→ 3.16% · 28,6134 Jul 25
What shareholders were asked to approve
1 proposal passed only on promoter votes

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 26 Sep 2025
See the official result
1
To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended 31 March 2025, together with the Reports of the Board of Directors and the Auditors thereon.
Backed by 100% of shareholders other than promotersneeded 50%
16.29 L votes for, 66 against · 0% of mutual funds and other big investors said no
2
To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended 31 March 2025, together with the Report of the Auditors thereon.
Backed by 100% of shareholders other than promotersneeded 50%
16.29 L votes for, 66 against · 0% of mutual funds and other big investors said no
3
To declare dividend on equity shares for the financial year ended 31 March 2025.
Backed by 100% of shareholders other than promotersneeded 50%
16.29 L votes for, 43 against · 0% of mutual funds and other big investors said no
4
To appoint a Director in place of Mr. Ajaykumar Mansukhlal Patel (DIN: 00183745) who retires by rotation and being eligible, offers himself for re-appointment.
Backed by 100% of shareholders other than promotersneeded 50%
16.28 L votes for, 477 against · 0% of mutual funds and other big investors said no
5
Re-appointment of Mr. Chintan Nitinkumar Shah (DIN: 00183618), as the Managing Director of the Company for a period of one (1) year with effect from 01 February 2026 and fixation of remuneration.
⚑ Passed only because promoters voted yes
Backed by 65% of shareholders other than promotersneeded 75%
10.58 L votes for, 5.70 L against · 36% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 42 named members
owning 72.0% between them · as of 2026-06-30
Shekhar Rasiklal Somani23.07%
Chintan Nitinkumar Shah20.94%
Ajay Mansukhlal Patel20.16%
Priti Ajay Patel3.85%
Chintan N Shah (HUF)1.91%
Shital Chintan Shah0.99%
Kajalben Shekharkumar Somani0.93%
Darshana Nitinkumar Shah0.17%

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.